clinical outcome assessments for clinical trials in rare tauopathies
Published 4 years ago • 167 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
8:01
dementia with lewy bodies | composite cognitive outcome measure | adpd
-
28:20
first phase 3 clinical trials targeting the tauopathy of alzheimer’s disease - claude wischik
-
59:38
clinical trials, fad variants, and the etiology of alzheimer’s disease
-
9:01
longitudinal clinical outcomes of tau-pet-positive individuals
-
4:55
measuring cognition in pediatric oncology clinical trials
-
2:02
the role of phosphorylated tau in clinical trials
-
4:03
challenges faced when diagnosing progressive tauopathies
-
17:43
translational clinical trials in neuro-oncology - nicholas butowski, md
-
3:53
promising new developments in tauopathy research
-
34:44
sens5 - clearance of pathological tau protein with immunotherapy
-
1:59
what is a tauopathy?
-
1:09:53
potential role of extracellular tau in development and spread of tauopathy
-
15:07
2022 nhpdd day 1, session 1, part 4
-
1:16:30
clinical trial showcase | 37th annual #hdsaconvention
-
58:54
aanp teaching rounds - september 25, 2023 - tauopathies
-
3:36
the importance of new methods for monitoring tau pathology
-
1:24
markers of of tau pathology in alzheimer’s disease
-
1:16
multi-pet tracers reveal the complex nature of 4r tauopathies